J&J’s ASR hip implants and transvaginal mesh devices have raised a number of safety concerns, so it is not surprising that the government is investigating the practices the company used in bringing these devices to the market
(PRWEB) February 22, 2013
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, is keeping consumers up-to-date on the latest news about metal-on-metal hip implants and transvaginal mesh litigations. According to a Bloomberg Businessweek report published on February 22nd, Johnson & Johnson disclosed separate government investigations over its transvaginal mesh implants and recalled ASR hip devices. So far, the company is facing 10,000 lawsuits over the ASR and another 1,800 over its Gynecare Prolift transvaginal mesh.
“J&J’s ASR hip implants and transvaginal mesh devices have raised a number of safety concerns, so it is not surprising that the government is investigating the practices the company used in bringing these devices to the market,” said Daniel C. Burke, Senior Litigation Counsel at Parker Waichman LLP. “We continue to receive many inquiries from patients who have been injured due to metal-on-metal hip implants and transvaginal mesh.” The national personal injury firm offers free legal advice to patients implanted with these devices.
Bloomberg Businessweek reports that, according to a regulatory filing, Johnson & Johnson stated that, “The government is investigating whether any person or entity submitted or caused to be submitted false claims or false statements affecting federal health-care programs in connection with the marketing and use of the ASR XL hip device.” The company also said that “The government has since made additional informal requests for the production of documents.” The inquiry was made by the U.S. Justice Department.
Johnson & Johnson’s DePuy unit recalled 93,000 ASR hip implants in 2010, citing a failure rate of 12 percent in five years. More recent data from an Australian registry indicates a revision rate upwards of 40 percent. There are over 10,000 lawsuits pending over the device; the first of these has gone to trial in Los Angeles state court (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County). Plaintiff Loren Kransky alleges that his DePuy ASR hip implant is defective and caused serious complications by releasing a toxic amount of metal ions, leading to his having to undergo revision surgery.
According to Bloomberg Businessweek, J&J also said that California’s attorney general contacted them in October about marketing transvaginal mesh for hernia and urogynecological purposes. Johnson & Johnson reportedly said that the probe involved 42 states. Transvaginal mesh devices are approved to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI).
Last August, Johnson & Johnson stopped selling the Gynecare Prolift along with three other transvaginal mesh devices. The company is facing 1,800 lawsuits over the mesh implant, the first of which is currently underway in the New Jersey state court Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey (Atlantic City).
Parker Waichman LLP continues to offer free legal consultations to victims of metal-on-metal hip implant injuries and transvaginal mesh injuries. If you or a loved one experienced premature failure of your implant or other health problems associated with a metal-on-metal hip implant, please contact their office by visiting the firm's Defective Hip Implants page at yourlawyer.com. If you or a loved one experienced complications following POP and stress urinary incontinence (SUI) surgery with mesh, please visit the firm's transvaginal mesh injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney